• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用丁香酚成功治疗实验性白色念珠菌性角膜炎。

Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.

作者信息

Hassan Heba A, Geniady Mahmoud M, Abdelwahab Sayed F, Abd-Elghany Manal I, Sarhan Hatem A, Abdelghany Ahmed A, Kamel Mohamed S, Rodriguez Alejandra E, Alio Jorge L

机构信息

Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, Minia, Egypt.

Ophthalmology Department, Faculty of Medicine, Minia University, Minia, Egypt.

出版信息

Ophthalmic Res. 2018;60(2):69-79. doi: 10.1159/000488907. Epub 2018 Jul 3.

DOI:10.1159/000488907
PMID:29969774
Abstract

PURPOSE

To determine the efficacy of eugenol for the treatment of Candida keratitis in an experimental model.

METHODS

The in vitro antifungal activity of eugenol and fluconazole was tested against C. albicans strains via the microbroth dilution method. An experimental model of Candida albicans keratitis was used. Rabbits were classified into those that received no treatment (control; group 1) and those that started eugenol treatment immediately (group 2) or after 4 days (group 3) of keratitis induction (n = 12-16 rabbits/group). The 2 treatment groups were assigned to 50 μL of 4 mg/mL eugenol drops hourly for 15 days, while the control group received saline. Corneal penetration of eugenol was measured using HPLC, and corneal toxicity was evaluated clinically and histopathologically.

RESULTS

The in vitro minimum inhibitory concentrations of eugenol and fluconazole against C. albicans were 2 and > 0.4 mg/mL, respectively. A 4-mg/mL preparation of eugenol in propylene glycol was the maximum nontoxic dose on rabbit corneas as suggested by clinical and histopathologic findings. At least 75% of all eugenol-treated eyes recovered from keratitis, with improvement in the remaining 25% of the eyes compared to controls.

CONCLUSIONS

Eugenol can act as a natural, safe, and effective treatment for fungal keratitis, regardless of whether treatment is started immediately or after 4 days of keratitis induction.

摘要

目的

在实验模型中确定丁香酚治疗白色念珠菌性角膜炎的疗效。

方法

通过微量肉汤稀释法检测丁香酚和氟康唑对白色念珠菌菌株的体外抗真菌活性。使用白色念珠菌性角膜炎的实验模型。将兔子分为未接受治疗的组(对照组;第1组)和在角膜炎诱导后立即(第2组)或4天后(第3组)开始丁香酚治疗的组(每组12 - 16只兔子)。两个治疗组每小时滴入50 μL 4 mg/mL的丁香酚滴眼液,持续15天,而对照组接受生理盐水。使用高效液相色谱法测量丁香酚的角膜渗透率,并通过临床和组织病理学评估角膜毒性。

结果

丁香酚和氟康唑对白色念珠菌的体外最低抑菌浓度分别为2和> 0.4 mg/mL。临床和组织病理学结果表明,丙二醇中4 mg/mL的丁香酚制剂是兔子角膜的最大无毒剂量。所有接受丁香酚治疗的眼睛中至少75%从角膜炎中恢复,与对照组相比,其余25%的眼睛有所改善。

结论

无论在角膜炎诱导后立即开始治疗还是4天后开始治疗,丁香酚都可作为真菌性角膜炎的天然、安全且有效的治疗方法。

相似文献

1
Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.局部用丁香酚成功治疗实验性白色念珠菌性角膜炎。
Ophthalmic Res. 2018;60(2):69-79. doi: 10.1159/000488907. Epub 2018 Jul 3.
2
Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.局部应用卡泊芬净治疗兔白色念珠菌性角膜炎模型
Antimicrob Agents Chemother. 2005 Apr;49(4):1359-63. doi: 10.1128/AAC.49.4.1359-1363.2005.
3
Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.联合局部用氟康唑和皮质类固醇治疗实验性白色念珠菌性角膜真菌病。
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2634-43. doi: 10.1167/iovs.02-1135.
4
Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.临时配制的咪康唑滴眼液治疗白色念珠菌性角膜真菌病的疗效和安全性。
Int Ophthalmol. 2018 Oct;38(5):2089-2100. doi: 10.1007/s10792-017-0707-z. Epub 2017 Sep 12.
5
Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.米卡芬净与氟康唑治疗兔实验性念珠菌性角膜炎的比较。
Cornea. 2007 Apr;26(3):336-42. doi: 10.1097/ICO.0b013e31802cd8a8.
6
Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.白色念珠菌与非白色念珠菌角膜分离株的抗真菌药敏对比分析。
Cornea. 2015 May;34(5):576-9. doi: 10.1097/ICO.0000000000000380.
7
Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.离子导入法和 PACK-CXL 在体内模型中对抗真菌药物角膜浓度的影响。
Cornea. 2018 Nov;37(11):1463-1467. doi: 10.1097/ICO.0000000000001696.
8
Orally administered antifungal therapy for experimental keratomycosis.用于实验性角膜真菌病的口服抗真菌治疗
Trans Am Ophthalmol Soc. 1990;88:685-725.
9
Efficacy of a Fixed Combination of Tetracycline, Chloramphenicol, and Colistimethate Sodium for Treatment of Candida albicans Keratitis.四环素、氯霉素和多粘菌素甲磺酸钠固定组合治疗白色念珠菌角膜炎的疗效
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4292-4298. doi: 10.1167/iovs.17-22047.
10
Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: Study in a Fungal Keratitis Model.固体分散体嵌入溶菌微针提高两性霉素 B 的抗真菌活性:真菌角膜炎模型研究。
Mol Pharm. 2023 Dec 4;20(12):6246-6261. doi: 10.1021/acs.molpharmaceut.3c00647. Epub 2023 Nov 17.

引用本文的文献

1
Management of corneal injuries in spaceflight and recommendations for planetary missions.航天飞行中角膜损伤的管理及行星任务建议
NPJ Microgravity. 2025 Mar 11;11(1):8. doi: 10.1038/s41526-025-00462-3.
2
Inhibitory effect of natural compounds on quorum sensing system in : a helpful promise for managing biofilm community.天然化合物对[具体对象]群体感应系统的抑制作用:对管理生物膜群落的有益前景。 (注:原文中“in :”表述有误,可能遗漏了具体内容,这里按正确理解翻译)
Front Pharmacol. 2024 Apr 2;15:1350391. doi: 10.3389/fphar.2024.1350391. eCollection 2024.
3
Eugenol: A novel therapeutic agent for the inhibition of species infection.
丁香酚:一种新型的抑制物种感染的治疗剂。
Front Pharmacol. 2022 Aug 9;13:872127. doi: 10.3389/fphar.2022.872127. eCollection 2022.
4
Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against Species.天然化合物:作为针对[具体物种]的抗生物膜剂的充满希望的前景
Front Pharmacol. 2022 Jul 11;13:917787. doi: 10.3389/fphar.2022.917787. eCollection 2022.
5
Optimal Design of Novel Microemulsions-Based Two-Layered Dissolving Microneedles for Delivering Fluconazole in Treatment of Fungal Eye Infection.用于递送氟康唑治疗真菌性眼部感染的新型微乳基双层溶蚀微针的优化设计
Pharmaceutics. 2022 Feb 22;14(3):472. doi: 10.3390/pharmaceutics14030472.
6
Update on the management of fungal keratitis.真菌性角膜炎的治疗进展。
Int Ophthalmol. 2021 Sep;41(9):3249-3256. doi: 10.1007/s10792-021-01873-3. Epub 2021 Apr 30.
7
Production of eugenol from fungal endophytes sp. and sp. isolated from leaves.从叶片中分离出的真菌内生菌[具体菌种1]和[具体菌种2]生产丁香酚。
PeerJ. 2019 Feb 12;7:e6427. doi: 10.7717/peerj.6427. eCollection 2019.